Lupin trades jubilantly on the bourses

20 Aug 2015 Evaluate

Lupin is currently trading at Rs. 1900.00, up by 104.65 points or 5.83% from its previous closing of Rs. 1795.35 on the BSE.

The scrip opened at Rs. 1820.00 and has touched a high and low of Rs. 1939.90 and Rs. 1815.50 respectively. So far 263697 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2112.00 on 08-Apr-2015 and a 52 week low of Rs. 1214.35 on 20-Aug-2014.

Last one week high and low of the scrip stood at Rs. 1939.90 and Rs. 1750.00 respectively. The current market cap of the company is Rs. 85493.45 crore.

The promoters holding in the company stood at 46.59% while Institutions and Non-Institutions held 43.57% and 9.84% respectively.

Drug major Lupin has opened a research and development (R&D) centre for inhalation products at Coral Springs in Florida, the US.  The facility will focus on the R&D of inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.

With the talent and resources Florida provides, the company’s Coral Springs expansion will further strengthen its ability to bring quality, affordable pharmaceuticals to patients in the United States and other key markets globally.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products.

Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×